| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Heartbeam, Inc. (BEAT) has 2 insiders with recent SEC Form 4 filings, including 2 buys and 11 sells. BEAT is classified in the Health Care Technology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 2.90M | $2.59M | - | |
| Dir | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 18, 2025 | De Urioste George67 | Director | Sell | 57,146 | $3.19 | $182,090.03 | -63.3% | -53.5% | - | |
| Dec 17, 2025 | Strome Mark E | 10% Owner | Sell | 250,000 | $3.58 | $895,000.00 | -7.9% | -57.7% | - | |
| Feb 14, 2025 | Ferrari Richard54 | Director | Buy | 29,412 | $1.70 | $50,000.40 | +19.6% | -26.1% | -37.6% | |
| Feb 14, 2025 | Cruickshank Tim | CFO | Buy | 17,647 | $1.70 | $29,999.90 | New | -26.1% | -37.6% | |
| Sep 6, 2024 | De Urioste George67 | Director | Sell | 1,674 | $2.34 | $3,917.16 | -2.8% | +35.9% | -41.6% | |
| Aug 30, 2024 | De Urioste George67 | Director | Sell | 5,500 | $2.31 | $12,705.00 | -8.6% | +30.2% | -42.6% | |
| Aug 27, 2024 | De Urioste George67 | Director | Sell | 2,194 | $2.26 | $4,958.44 | -3.3% | +25.8% | -47.6% | |
| Aug 26, 2024 | De Urioste George67 | Director | Sell | 2,800 | $2.31 | $6,464.00 | -2.1% | +24.7% | -49.3% | |
| Sep 29, 2023 | De Urioste George67 | Director | Sell | 5,500 | $2.06 | $11,330.00 | -13.2% | +16.3% | +7.4% | |
| Sep 28, 2023 | De Urioste George67 | Director | Sell | 9,834 | $2.05 | $20,189.74 | -9.7% | +11.3% | +13.2% |